DALLAS, Oct. 22, 2025 /PRNewswire/ -- Despite record spending on customer success, most SaaS companies are still losing ground on retention. A new study from SBI Growth Advisory and QuadSci uncovers ...
SBI-100 Ophthalmic Emulsion, a CB1 agonist/activator delivered as a topical eye drop, was developed to treat patients with elevated intraocular pressure Phase 2 study evaluating efficacy and safety ...
NDTV Profit on MSN
Rupee likely to bounce back strongly in second half of FY27: SBI study
While INR is the most depreciated currency, it is not the most volatile, said the report from SBI's Economic Research ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Skye Bioscience has treated the first patient in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback